EQS-PVR: SAF-HOLLAND SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

04.05.26 16:41 Uhr

Werte in diesem Artikel
Aktien

20,00 EUR 0,48 EUR 2,46%

EQS Voting Rights Announcement: SAF-HOLLAND SE
SAF-HOLLAND SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

04.05.2026 / 16:41 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: SAF-HOLLAND SE
Street: Hauptstraße 26
Postal code: 63856
City: Bessenbach
Germany
Legal Entity Identifier (LEI): 222100QJQLUJHWREL058

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: Stowers Institute for Medical Research
City of registered office, country: Kansas City, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
28 Apr 2026

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 3.01 % 0.00 % 3.01 % 45394302
Previous notification n/a % n/a % n/a % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000SAFH001 0 1368078 0.00 % 3.01 %
Total 1368078 3.01 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
-Stowers Institute for Medical Research % % %
-American Century Companies % % %
-American Century Investment Management, Inc. 3.01 % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
Underlying accounts, collectively, represent 3,01% ownership in the issuer. Each underlying acct. is the legal owner of its shares. ACIM is the investment adviser for each acct. and has voting authority for each. SIMR owns shares representing 66.7% of the voting rights of ACC. ACIM is 100% owned by ACC. SIMR is a not-for-profit and not controlled by any legal entity. 

Date
30 Apr 2026



04.05.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: SAF-HOLLAND SE
Hauptstraße 26
63856 Bessenbach
Germany
Internet: www.safholland.com

 
End of News EQS News Service

2320678  04.05.2026 CET/CEST

Nachrichten zu SAF-HOLLAND SE

Analysen zu SAF-HOLLAND SE

DatumRatingAnalyst
08.05.2026SAF-HOLLAND SE HoldDeutsche Bank AG
08.05.2026SAF-HOLLAND SE BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.05.2026SAF-HOLLAND SE KaufenDZ BANK
15.04.2026SAF-HOLLAND SE HoldDeutsche Bank AG
24.03.2026SAF-HOLLAND SE BuyWarburg Research
DatumRatingAnalyst
08.05.2026SAF-HOLLAND SE BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.05.2026SAF-HOLLAND SE KaufenDZ BANK
24.03.2026SAF-HOLLAND SE BuyWarburg Research
20.03.2026SAF-HOLLAND SE BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
19.03.2026SAF-HOLLAND SE BuyWarburg Research
DatumRatingAnalyst
08.05.2026SAF-HOLLAND SE HoldDeutsche Bank AG
15.04.2026SAF-HOLLAND SE HoldDeutsche Bank AG
20.02.2026SAF-HOLLAND SE HoldDeutsche Bank AG
16.10.2025SAF-HOLLAND SE HoldDeutsche Bank AG
08.08.2025SAF-HOLLAND SE HoldDeutsche Bank AG
DatumRatingAnalyst
25.03.2021SAF-HOLLAND SE Inhaber-Akt ReduceKepler Cheuvreux
03.12.2020SAF-HOLLAND SE Inhaber-Akt ReduceKepler Cheuvreux
26.11.2020SAF-HOLLAND SE Inhaber-Akt ReduceKepler Cheuvreux
18.11.2020SAF-HOLLAND SE Inhaber-Akt ReduceKepler Cheuvreux
21.10.2020SAF-HOLLAND SE Inhaber-Akt ReduceKepler Cheuvreux

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für SAF-HOLLAND SE nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen